Six University-launched businesses (spin-offs and tech-based companies) will have the chance to participate in this free programme that will be held from February to May 2023. The programme is an initiative by the European project BOOGIE-U.
UAB researchers have developed a magnetic material capable of imitating the way the brain stores information. The material makes it possible to emulate the synapses of neurons and mimic, for the first time, the learning that occurs during deep sleep.
On 18 November at 9:30 a.m. the offices of the Vice Rector for Innovation and Strategic Projects and the Vice Rector for Students and Employability organise a "Science and Entrepreneurship in Feminine" seminar to raise awareness of women standing out in innovation and entrepreneurship at the UAB campus, and provide specific resources for women interested in innovating and/or becoming entrepreneurs. The session will be held in the UAB Theatre Hall.
Inhibition of the ERK5 protein kinase reduces the proliferation and survival of endometrial cancer cells, and potentiates standard chemotherapy.
New UAB crowdfunding campaign to develop a simple sampling methodology for urban areas.
The TECNIO groups located on the UAB campus and Rosa M. Sebastián, Vice Rector for Innovation, Transfer and Entrepreneurship and director of the UAB Research Park, participated in the First TECNIO Conference, which debuted with the challenges faced by the knowledge transfer ecosystem to turn Catalonia into a technology innovation pole.
The Gran Teatre del Liceu de Barcelona recently premiered La gata perduda, a participative opera in which neighbours and entities from the Raval district in Barcelona were the actors. The opera is the result of the Traction project, focused on opera as a social transformation through audiovisual art and emerging technologies; a project in which the UAB research group TransMedia Catalonia also participated.
The spin-off from the Universitat Autònoma de Barcelona and the Hospital de Santa Creu i Sant Pau Research Institute specialises in the development of nanotechnology-based cancer treatments. The company announces the completion of a Seed financing round of total €2.8 M, led by the i&i Biotech Fund.
Researchers from the Biosensors and Bioanalysis group at the IBB, led by María Isabel Pividori, will work on the development and validation of a tool to quickly and easily measure biomarkers of fever severity in children, with the aim of increasing child survival globally. The research will be carried out within the framework of the recently launched European project EChiLiBRiST.